HEALTH● LOWJul 31 · Jul 31, 2026, 2:45 PM
Handa Oncology Receives FDA Tentative Approval for OMCAZIO ( cabozantinib ) Capsules
tennesseedaily.com · United States
Handa Oncology has received tentative FDA approval for its OMCAZIO (cabozantinib) capsules. This marks a significant regulatory milestone for a new oncology treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH57m agoMamdani says 9/11 illnesses killed more than attacks didAl Jazeera [en]HEALTH3h agoAbia to distribute over 3 million insecticide-treated netsPremium TimesHEALTH3h agoAbia to distribute over 3 million insecticide-treated netsPremium TimesHEALTH3h agoCould GLP-1 Drugs Help You Live a Longer, Healthier Life?Singularity Hub